
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11066080
[patent_doc_number] => 20160263044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 15/163491
[patent_app_country] => US
[patent_app_date] => 2016-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7376
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/163491 | METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM | May 23, 2016 | Abandoned |
Array
(
[id] => 14548677
[patent_doc_number] => 10342775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Vitamin A for parenteral administration
[patent_app_type] => utility
[patent_app_number] => 15/575984
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575984 | Vitamin A for parenteral administration | May 19, 2016 | Issued |
Array
(
[id] => 12765940
[patent_doc_number] => 20180147148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => PHARMACEUTICAL COMPOSITION OF TERIFLUNOMIDE
[patent_app_type] => utility
[patent_app_number] => 15/575350
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575350 | PHARMACEUTICAL COMPOSITION OF TERIFLUNOMIDE | May 10, 2016 | Abandoned |
Array
(
[id] => 12165272
[patent_doc_number] => 09884029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Morphine controlled release system'
[patent_app_type] => utility
[patent_app_number] => 15/149578
[patent_app_country] => US
[patent_app_date] => 2016-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 21370
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15149578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/149578 | Morphine controlled release system | May 8, 2016 | Issued |
Array
(
[id] => 11045937
[patent_doc_number] => 20160242895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Tissue Prostheses for Repairing, Reconstructing and Replacing Damaged or Diseased Biological Structures and Associated Tissue'
[patent_app_type] => utility
[patent_app_number] => 15/144902
[patent_app_country] => US
[patent_app_date] => 2016-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8147
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144902 | Tissue prostheses for repairing, reconstructing and replacing damaged or diseased biological structures and associated tissue | May 2, 2016 | Issued |
Array
(
[id] => 12302331
[patent_doc_number] => 09937130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Sustained delivery of therapeutic agents to an eye compartment
[patent_app_type] => utility
[patent_app_number] => 15/138132
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15859
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15138132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/138132 | Sustained delivery of therapeutic agents to an eye compartment | Apr 24, 2016 | Issued |
Array
(
[id] => 14291935
[patent_doc_number] => 10286075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Embolization particle
[patent_app_type] => utility
[patent_app_number] => 15/566254
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 15250
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566254 | Embolization particle | Apr 14, 2016 | Issued |
Array
(
[id] => 11016682
[patent_doc_number] => 20160213636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/092391
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16229
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/092391 | Stable pharmaceutical composition and methods of using same | Apr 5, 2016 | Issued |
Array
(
[id] => 11016710
[patent_doc_number] => 20160213662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS'
[patent_app_type] => utility
[patent_app_number] => 15/086485
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 46532
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15086485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/086485 | Methods and devices for the treatment of ocular diseases in human subjects | Mar 30, 2016 | Issued |
Array
(
[id] => 11977523
[patent_doc_number] => 20170281677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'THERAPEUTIC COMPOSITION FOR VARIOUS SKIN CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/085404
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8713
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15085404
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/085404 | THERAPEUTIC COMPOSITION FOR VARIOUS SKIN CONDITIONS | Mar 29, 2016 | Abandoned |
Array
(
[id] => 11536034
[patent_doc_number] => 09610427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-04
[patent_title] => 'Narrow profile composition-releasing expandable medical balloon catheter'
[patent_app_type] => utility
[patent_app_number] => 15/085745
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 17263
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15085745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/085745 | Narrow profile composition-releasing expandable medical balloon catheter | Mar 29, 2016 | Issued |
Array
(
[id] => 11953939
[patent_doc_number] => 20170258091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'PROCESS FOR CONTROLLING BACTERIAL, FUNGAL AND VIRAL DISEASES IN CROPS OR PLANTS WITH SODIUM CHLORITE SOLUTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/065150
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2606
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15065150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/065150 | PROCESS FOR CONTROLLING BACTERIAL, FUNGAL AND VIRAL DISEASES IN CROPS OR PLANTS WITH SODIUM CHLORITE SOLUTIONS | Mar 8, 2016 | Abandoned |
Array
(
[id] => 12239955
[patent_doc_number] => 20180072819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'WATER-SOLUBLE ESTERIFIED CELLULOSE ETHERS HAVING A LOW DEGREE OF NEUTRALIZATION'
[patent_app_type] => utility
[patent_app_number] => 15/550097
[patent_app_country] => US
[patent_app_date] => 2016-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12370
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550097
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550097 | Water-soluble esterified cellulose ethers having a low degree of neutralization | Mar 7, 2016 | Issued |
Array
(
[id] => 12204763
[patent_doc_number] => 20180049989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'PHARMACEUTICAL COMPOSITION OF TIZANIDINE AND PROCESS FOR PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/555748
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2852
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555748
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555748 | PHARMACEUTICAL COMPOSITION OF TIZANIDINE AND PROCESS FOR PREPARING THE SAME | Mar 3, 2016 | Abandoned |
Array
(
[id] => 11053368
[patent_doc_number] => 20160250330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'SCINTILLATOR NANOCRYSTAL-CONTAINING COMPOSITIONS AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/052526
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 37540
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15052526
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/052526 | Scintillator nanocrystal-containing compositions and methods for their use | Feb 23, 2016 | Issued |
Array
(
[id] => 12466443
[patent_doc_number] => 09987389
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Articles with odor-controlling composition
[patent_app_type] => utility
[patent_app_number] => 15/019879
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13580
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019879 | Articles with odor-controlling composition | Feb 8, 2016 | Issued |
Array
(
[id] => 10812063
[patent_doc_number] => 20160158223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'CONTROLLED RELEASE HYDROCODONE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/019609
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12696
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019609
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019609 | Controlled release hydrocodone formulations | Feb 8, 2016 | Issued |
Array
(
[id] => 10812064
[patent_doc_number] => 20160158224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'CONTROLLED RELEASE HYDROCODONE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/019695
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12695
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019695 | Controlled release hydrocodone formulations | Feb 8, 2016 | Issued |
Array
(
[id] => 10805135
[patent_doc_number] => 20160151292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'CONTROLLED RELEASE HYDROCODONE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/019106
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12689
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019106
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019106 | Controlled release hydrocodone formulations | Feb 8, 2016 | Issued |
Array
(
[id] => 10805131
[patent_doc_number] => 20160151288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'CONTROLLED RELEASE HYDROCODONE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/019279
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12699
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019279
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019279 | Controlled release hydrocodone formulations | Feb 8, 2016 | Issued |